Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.8 EUR | -8.80% |
|
+2.70% | 0.00% |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
Jul. 12 | Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market | RE |